WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience MBF Stereo Investigator
QUICK SEARCH:   [advanced]


     
-


HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP
The Journal of Neuroscience, August 30, 2006, 26(35):9047-9056; doi:10.1523/JNEUROSCI.2797-06.2006

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow View eLetters for this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (16)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Green, K. N.
Right arrow Articles by LaFerla, F. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Green, K. N.
Right arrow Articles by LaFerla, F. M.

 Previous Article  |  Next Article 

Neurobiology of Disease
Glucocorticoids Increase Amyloid-beta and Tau Pathology in a Mouse Model of Alzheimer’s Disease

Kim N. Green, Lauren M. Billings, Benno Roozendaal, James L. McGaugh, and Frank M. LaFerla

Department of Neurobiology and Behavior, and Center for the Neurobiology of Learning and Memory, University of California, Irvine, Irvine, California 92697-4545

Correspondence should be addressed to Frank M. LaFerla, Department of Neurobiology and Behavior, University of California, Irvine, 1109 Gillespie Neuroscience Building, Irvine, CA 92697-4545. Email: laferla{at}uci.edu

Various environmental and genetic factors influence the onset and progression of Alzheimer’s disease (AD). Dysregulation of the hypothalamic–pituitary–adrenal (HPA) axis, which controls circulating levels of glucocorticoid hormones, occurs early in AD, resulting in increased cortisol levels. Disturbances of the HPA axis have been associated with memory impairments and may contribute to the cognitive decline that occurs in AD, although it is unknown whether such effects involve modulation of the amyloid beta-peptide (Abeta) and tau. Using in vitro and in vivo experiments, we report that stress-level glucocorticoid administration increases Abeta formation by increasing steady-state levels of amyloid precursor protein (APP) and beta-APP cleaving enzyme. Additionally, glucocorticoids augment tau accumulation, indicating that this hormone also accelerates the development of neurofibrillary tangles. These findings suggest that high levels of glucocorticoids, found in AD, are not merely a consequence of the disease process but rather play a central role in the development and progression of AD.

Key words: corticosterone; Abeta peptide; Alzheimer’s disease; glucocorticoids; tau; stress

Received April 11, 2006; accepted July 23, 2006.

Correspondence should be addressed to Frank M. LaFerla, Department of Neurobiology and Behavior, University of California, Irvine, 1109 Gillespie Neuroscience Building, Irvine, CA 92697-4545. Email: laferla{at}uci.edu




This article has been cited by other articles:


Home page
 NeurologyHome page
M. A. Reger, G. S. Watson, P. S. Green, C. W. Wilkinson, L. D. Baker, B. Cholerton, M. A. Fishel, S. R. Plymate, J.C.S. Breitner, W. DeGroodt, et al.
Intranasal insulin improves cognition and modulates {beta}-amyloid in early AD
Neurology, February 5, 2008; 70(6): 440 - 448.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
A. Berson, M. Knobloch, M. Hanan, S. Diamant, M. Sharoni, D. Schuppli, B. C. Geyer, R. Ravid, T. S. Mor, R. M. Nitsch, et al.
Changes in readthrough acetylcholinesterase expression modulate amyloid-beta pathology
Brain, January 1, 2008; 131(1): 109 - 119.
[Abstract] [Full Text] [PDF]

Home page
 AJGPHome page
E. J. Lenze and B. H. Mulsant
Biomarkers in Geriatric Psychiatry
Am J Geriatr Psychiatry, October 1, 2007; 15(10): 827 - 831.
[Full Text] [PDF]

Home page
 Cereb CortexHome page
J. J. Cerqueira, R. Taipa, H. B. M. Uylings, O. F. X. Almeida, and N. Sousa
Specific Configuration of Dendritic Degeneration in Pyramidal Neurons of the Medial Prefrontal Cortex Induced by Differing Corticosteroid Regimens
Cereb Cortex, September 1, 2007; 17(9): 1998 - 2006.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
J.-E. Kang, J. R. Cirrito, H. Dong, J. G. Csernansky, and D. M. Holtzman
Acute stress increases interstitial fluid amyloid-beta via corticotropin-releasing factor and neuronal activity
PNAS, June 19, 2007; 104(25): 10673 - 10678.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
R. A. Rissman, K.-F. Lee, W. Vale, and P. E. Sawchenko
Corticotropin-Releasing Factor Receptors Differentially Regulate Stress-Induced Tau Phosphorylation
J. Neurosci., June 13, 2007; 27(24): 6552 - 6562.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
J. I. Castillo-Quan and J. M. Perez-Osorio
Cortisol Secretion in Patients With Type 2 Diabetes: Relationship With Chronic Complications: Response to Chiodini et al.
Diabetes Care, June 1, 2007; 30(6): e49 - e49.
[Full Text] [PDF]

eLetters:

Read all eLetters

This could be due to a reduced DHEA to cortisol ratio...
James M. Howard
J. Neurosci. Online, 21 Jun 2007 [Full text]

-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help
-
Copyright 2008 by Society for Neuroscience ONLINE ISSN: 1529-2401
-